BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28374815)

  • 1. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.
    Tramontano AC; Sheehan DF; Yeh JM; Kong CY; Dowling EC; Rubenstein JH; Abrams JA; Inadomi JM; Schrag D; Hur C
    Am J Gastroenterol; 2017 Aug; 112(8):1256-1264. PubMed ID: 28374815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.
    Verbeek RE; Leenders M; Ten Kate FJ; van Hillegersberg R; Vleggaar FP; van Baal JW; van Oijen MG; Siersema PD
    Am J Gastroenterol; 2014 Aug; 109(8):1215-22. PubMed ID: 24980881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
    Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
    Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
    El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
    Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.
    Wenker TN; Tan MC; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2018 Nov; 63(11):3112-3119. PubMed ID: 30109579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
    Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
    Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
    Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
    Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
    Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
    Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
    Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receipt of Serial Endoscopy Procedures Prior to Esophageal Adenocarcinoma Diagnosis Is Associated with Better Survival.
    Cummings LC; Kou TD; Chak A; Schluchter MD; Margevicius S; Cooper GS
    Dig Dis Sci; 2022 Mar; 67(3):1036-1044. PubMed ID: 33881677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
    Wong T; Tian J; Nagar AB
    Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
    Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
    Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.